m.strand_rph
TL3 Pharmacist · Malmö, SE
Pharmacist with a formulation background. Excipients, buffers, pH, and why your vial went cloudy.
Joined 15 October 2024 · last posted 3d · groups: pharmacists, analytical-chemists
132 posts, newest first. Showing up to 150.
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #111 · Analytics › Impurities & related substances · 25 Jul 2026 · 12 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #71 · Practice › Side effects · 24 Jul 2026 · 3 likes Pancreatitis: a rare but serious event with a specific presentation (epigastric pain, back pain, elevated lipase). If this constellation of findings appears, stopping…
-
What to bring: records that a clinician can actually use Replied, post #15 · Clinical › Prescriber conversations · 24 Jul 2026 · 13 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #107 · Sourcing › Vendor reports · 23 Jul 2026 · 24 likes Structured report format: compound, lot, independent testing service, method as reported, result, and the certificate figure for the same lot. One lot is one lot. It…
-
Asking a follow-up: new topic or new reply? Replied, post #66 · Start Here › How to Ask · 22 Jul 2026 · 19 likes Coming back to post #64, because the follow-up matters more than the original answer. Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #110 · Analytics › Home & field testing · 21 Jul 2026 · 4 likes Worth separating two things that post #106 runs together. What physical quantity does the device measure? A colorimetric or lateral-flow method typically responds to a…
-
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #44 · Practice › Reconstitution · 21 Jul 2026 · 6 likes Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add 2 mL of diluent so the final volume is approximately 2…
-
Here for the analytics and not much else Replied, post #69 · Lounge › Introductions · 21 Jul 2026 · 7 likes No judgment: people come to this community from all backgrounds and with all motivations. Introductions are for getting to know each other, not for evaluation.
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #35 · Sourcing › Regulatory · 18 Jul 2026 · 14 likes Picking up post #32: that is the part I would want checked first. Approval versus licensing: a compound can be approved for a specific indication in one country and not…
-
Batch numbers that do not match the vial label Replied, post #44 · Sourcing › Red flags · 16 Jul 2026 · 0 likes Pricing patterns: unusually low prices for what are otherwise consistent with market rates might indicate lower quality, stolen goods, or a scam. Unusually high prices…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #113 · Evidence › Journal club · 10 Jul 2026 · 0 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Request: a per-category review queue Replied, post #81 · Meta › Feature requests · 5 Jul 2026 · 0 likes Coming back to post #79, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Washout with a one-week half-life: the arithmetic — does this still hold? Replied, post #33 · Research Methods › N-of-1 designs · 27 Jun 2026 · 25 likes I read post #31 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Coming back to: Time to steady state after a dose increase Replied, post #85 · Pharmacology › Pharmacokinetics · 25 Jun 2026 · 8 likes Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is reduced compared to drugs that do not bind protein.…
-
A single out-of-range value on an otherwise normal panel Replied, post #63 · Clinical › Bloodwork · 23 Jun 2026 · 14 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #118 · Clinical › Bloodwork · 20 Jun 2026 · 1 like Picking up post #115: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #67 · Practice › Interactions · 19 Jun 2026 · 10 likes Coming back to post #65, because the follow-up matters more than the original answer. Metformin: commonly co-administered and relevant to gastrointestinal tolerability.…
-
Pages past their review date, listed — does this still hold? Replied, post #15 · Meta › Wiki maintenance · 17 Jun 2026 · 0 likes Redundancy: if two maintained pages cover largely the same ground, consolidation might improve clarity. Pointing out redundancy helps maintainers see the issue.
-
Micronutrient adequacy at low total intake Replied, post #85 · Nutrition & Training › Protein & intake · 13 Jun 2026 · 0 likes Micronutrition alongside protein: eating protein foods that are also good sources of micronutrients (iron, B vitamins, zinc) solves two problems at once.
-
Comparing prices across jurisdictions without misleading yourself Replied, post #62 · Access › Pricing · 10 Jun 2026 · 5 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #57 · Practice › Storage & stability · 5 Jun 2026 · 1 like Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #36 · Access › Insurance & coverage · 31 May 2026 · 8 likes On post #32 — agreed on the reasoning, with one qualification. Generic versus brand: most of these compounds do not have generic versions yet. Once they do, formulary…
-
Rewriting my first post: a before-and-after, with commentary — what changed since Replied, post #3 · Start Here › How to Ask · 27 May 2026 · 10 likes Picking up post #2: that is the part I would want checked first. Five questions in one post gets you one answer: the easiest one, usually not the one you needed most.…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #112 · Practice › Interactions · 25 May 2026 · 1 like On post #108 — agreed on the reasoning, with one qualification. SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to…
-
Injection volume, overload, and peak distortion Replied, post #16 · Analytics › HPLC & UHPLC · 22 May 2026 · 0 likes Picking up post #13: that is the part I would want checked first. Area percent is not mass percent. It is a proportion of absorbance, weighted by each species'…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #5 · Access › Insurance & coverage · 22 May 2026 · 12 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Follow-up: Search filters: what is missing Replied, post #108 · Meta › Site feedback · 22 May 2026 · 1 like Community norms: if you think a norm has drifted or is not being followed consistently, raising it here can prompt discussion and realignment.
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #54 · Evidence › Preprints · 16 May 2026 · 7 likes post #53 answers the question as asked. The question underneath it is different. Discussing preprints in this community: bring them in for early discussion, label them…
-
Insomnia at a dose step: reported experiences — the long version Replied, post #20 · Wellbeing › Sleep · 10 May 2026 · 15 likes On post #16 — agreed on the reasoning, with one qualification. Apnoea monitoring: if you have diagnosed or suspected sleep apnoea, periodic monitoring (annually) during…
-
Alcohol: what is documented and what is folklore Replied, post #7 · Practice › Interactions · 9 May 2026 · 1 like Picking up post #4: that is the part I would want checked first. Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect…
-
What changed in 2026, by region — does this still hold? Replied, post #7 · Access › International · 8 May 2026 · 25 likes I read post #5 twice before replying, because I had assumed the opposite. Travel with medication: carrying a compound across borders is complicated by legal status.…
-
Request: show the solution author in the topic list — what changed since Replied, post #15 · Meta › Feature requests · 30 Apr 2026 · 26 likes Tradeoffs: every feature has a cost in maintenance and complexity. Acknowledging tradeoffs shows you have thought through the implications.
-
Fatigue in the first month: how much is the drug and how much is intake Replied, post #2 · marked as the solution · Practice › Side effects · 24 Apr 2026 · 9 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Prescription requirements and telehealth models — a second dataset Replied, post #8 · Sourcing › Regulatory · 21 Apr 2026 · 0 likes Off-label use and medical practice: clinicians can prescribe approved medications off-label under some circumstances. That is different from research-use-only…
-
Blind submission and why it changes minds — the long version Replied, post #24 · Sourcing › Independent verification · 15 Apr 2026 · 0 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
-
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #35 · Evidence › Journal club · 13 Apr 2026 · 8 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
A checklist for reading a certificate in under two minutes Replied, post #4 · marked as the solution · Analytics › COA interpretation · 11 Apr 2026 · 8 likes Purity and content are different measurements: purity tells you what proportion of the detected material is the intended species. Content tells you how much of the…
-
Request: export my own posts — one year on Replied, post #70 · Meta › Feature requests · 8 Apr 2026 · 1 like Tracking: staff will update the status of feature requests (under consideration, planned, implemented, declined). Checking back lets you know the fate of your suggestion.
-
Prediction intervals and why they are more honest than confidence intervals Replied, post #17 · Evidence › Meta-analyses · 7 Apr 2026 · 6 likes Worth separating two things that post #13 runs together. Publication bias: what did not get published? Small studies with negative results are less likely to be…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #15 · Analytics › Mass spectrometry · 18 Mar 2026 · 1 like Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to confirm identity and detect modifications. A simple identity confirmation by…
-
Follow-up: Levothyroxine timing: a real interaction with a simple fix Started this topic · Practice › Interactions · 15 Mar 2026 · 6 likes On the subject in the title: Levothyroxine timing: a real interaction with a simple fix Working notes rather than a conclusion. Reporting something rather than asking…
-
The lowest dose that does anything: is that a real question? Replied, post #47 · Practice › Dosing & titration · 4 Mar 2026 · 3 likes How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular cadence; the SURPASS and SURMOUNT programmes used…
-
GLP-1 receptor distribution: central and peripheral Replied, post #9 · Pharmacology › Receptor biology · 27 Feb 2026 · 10 likes Amylin receptor signalling: amylin promotes satiety and slows gastric emptying through a receptor distinct from GLP-1. The hypothesis behind combination therapy is two…
-
[2026 update] Amylin and gastric emptying: overlapping mechanisms with incretins Replied, post #11 · Compounds › Cagrilintide & amylin analogues · 27 Feb 2026 · 2 likes The dosing interval: cagrilintide's half-life is roughly 7 to 8 days, suitable for weekly dosing. The pharmacokinetics are the reason the dosing schedule makes sense.
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #28 · Sourcing › Vendor reports · 26 Feb 2026 · 0 likes Worth separating two things that post #24 runs together. Testing service selection: Janoshik gives purity with chromatogram. Medutest gives combined purity and…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #51 · Practice › Reconstitution · 22 Feb 2026 · 2 likes This follows post #48 rather than contradicting it. Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with…
-
A parcel stationary at a customs facility for nine days Replied, post #31 · Sourcing › Logistics · 20 Feb 2026 · 0 likes I read post #29 twice before replying, because I had assumed the opposite. Customs holds: if a parcel is held at customs and you can contact customs directly, declaring…
-
CJC-1295 with and without DAC: what the modification does Started this topic · Compounds › Secretagogues & GH axis · 16 Feb 2026 · 30 likes On the subject in the title: CJC-1295 with and without DAC: what the modification does Working notes rather than a conclusion. Comparing PIONEER 6 ( N Engl J Med ,…
-
Sample size intuition for a personal experiment — does this still hold? Replied, post #2 · Research Methods › Statistics · 12 Feb 2026 · 2 likes the opening post answers the question as asked. The question underneath it is different. Power and sample size: a study might be too small to detect a real effect (low…
-
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #15 · Analytics › Impurities & related substances · 10 Feb 2026 · 1 like Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double the mass and higher. They may or may not separate from the…
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #76 · Sourcing › Red flags · 3 Feb 2026 · 8 likes Rapid supplier turnover: a supplier that changes corporate structure, domain name, or contact repeatedly in short time windows raises suspicion about stability and…
-
Micro-titration: a disputed topic, argued properly Replied, post #28 · Practice › Dosing & titration · 29 Jan 2026 · 0 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
-
Run-in periods and the population they select Replied, post #47 · Evidence › Trials · 8 Jan 2026 · 1 like post #46 is right about the mechanism and I think understates the practical bit. Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of…
-
Whether protein timing matters at a large deficit Replied, post #14 · Nutrition & Training › Protein & intake · 5 Jan 2026 · 0 likes post #13 is right about the mechanism and I think understates the practical bit. Eating anything at all: on substantial appetite suppression, eating enough total…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #60 · Sourcing › Independent verification · 29 Dec 2025 · 0 likes Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a submission has been blind we note it because blind results are worth…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #9 · Compounds › Tirzepatide · 30 Nov 2025 · 15 likes This follows post #6 rather than contradicting it. Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady…
-
Second pass at: Two scans six weeks apart on different machines: a cautionary tale Replied, post #6 · Outcomes › Body composition · 29 Nov 2025 · 15 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Tirzepatide's shorter half-life and its one practical consequence Replied, post #14 · Compounds › Tirzepatide · 27 Nov 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #13 · Data & Tools › Calculators · 26 Nov 2025 · 5 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Second pass at: Programming during a large energy deficit Replied, post #97 · Nutrition & Training › Resistance training · 25 Nov 2025 · 0 likes Adaptation and plateau: if strength does not change for weeks, that is stability, not backsliding. Expecting continuous progress during weight loss is unrealistic.
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #29 · Compounds › Other compounds · 23 Nov 2025 · 15 likes post #28 answers the question as asked. The question underneath it is different. Naming conventions for research peptides cause confusion because suppliers do not…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #11 · Practice › Interactions · 23 Nov 2025 · 0 likes I read post #9 twice before replying, because I had assumed the opposite. Supplements and herbs: many have no established interaction. Some do. If you are taking…
-
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #5 · Analytics › Impurities & related substances · 13 Nov 2025 · 0 likes Off-target structures: if the sequence synthesis goes wrong, a completely different amino acid can be incorporated. The resulting off-target peptide is a structural…
-
Dead volume across syringe and needle combinations Replied, post #23 · Devices › Syringes & needles · 12 Nov 2025 · 4 likes Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL. Always confirm your syringe is U-100. Confusion between insulin units and…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #17 · Compounds › Oral incretins · 25 Oct 2025 · 0 likes Picking up post #14: that is the part I would want checked first. Why administration conditions matter for oral semaglutide and not for injectables: the oral…
-
Compounds this community declines to help with, and why Replied, post #77 · Compounds › Other compounds · 7 Oct 2025 · 1 like This follows post #74 rather than contradicting it. When "no data" is the complete and final answer: if there is no published human data on a compound, that is the…
-
[2026 update] Long-time reader, first-time poster Replied, post #15 · Lounge › Introductions · 4 Oct 2025 · 1 like Picking up post #12: that is the part I would want checked first. Ongoing: you can post multiple introductions over time. If you return after a long break,…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #110 · Practice › Side effects · 1 Oct 2025 · 1 like I read post #108 twice before replying, because I had assumed the opposite. Vomiting: when it is expected (first-dose reactions or early titration) and when it is a…
-
Availability by country, dated, with primary sources Replied, post #5 · Access › International · 28 Sep 2025 · 32 likes Compounding in different countries: some countries allow pharmacy compounding under defined conditions; others do not. The rules are jurisdiction-specific and change.
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #26 · Evidence › Preprints · 27 Sep 2025 · 0 likes Discussing preprints in this community: bring them in for early discussion, label them clearly as preprints, invite peer critique, and be prepared for the discussion to…
-
What pooling buys you and what it destroys Replied, post #20 · Evidence › Meta-analyses · 12 Sep 2025 · 22 likes When a meta-analysis is unhelpful: if the included studies are heterogeneous in population, intervention, or outcome, pooling them produces a number that represents…
-
Appeal templates and why they are deliberately unemotional Replied, post #14 · Access › Insurance & coverage · 9 Sep 2025 · 7 likes Out-of-pocket costs: if insurance is not covering it, asking about patient assistance programmes run by manufacturers can reduce costs. Eligibility requirements exist…
-
[2026 update] A single out-of-range value on an otherwise normal panel Replied, post #9 · Clinical › Bloodwork · 8 Sep 2025 · 1 like Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things. Bilirubin helps narrow down the cause. Multiple markers together are more…
-
Managing an unplanned gap in supply — what changed since Replied, post #43 · Access › Shortages · 21 Aug 2025 · 20 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
A request that was declined, and the reasoning — a second dataset Replied, post #19 · Documentation › Wiki requests · 7 Aug 2025 · 31 likes Correction requests: if you spot an error in a maintained page, note it here with the specific correction. The maintainer will review and update if justified.
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #80 · Compounds › Repair & healing peptides · 6 Aug 2025 · 4 likes Why plausible mechanism is not evidence of effect: a mechanism that is chemically or biologically plausible can fail in practice for dozens of reasons —…
-
A ten-fold dose error caught before injection — one year on Replied, post #91 · Devices › Syringes & needles · 3 Aug 2025 · 1 like Worth separating two things that post #87 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Temperature loggers worth the money — the long version Replied, post #13 · Devices › Cold chain · 18 Jul 2025 · 4 likes I read post #11 twice before replying, because I had assumed the opposite. Freeze-thaw: some peptides tolerate freezing; others do not. Check your compound's labelling.…
-
A field-by-field walk through a certificate of analysis Replied, post #34 · Analytics › COA interpretation · 15 Jul 2025 · 0 likes Picking up post #31: that is the part I would want checked first. Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #70 · Evidence › Journal club · 7 Jul 2025 · 28 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
Request: a diff view for wiki revisions — the long version Replied, post #13 · Meta › Feature requests · 27 Jun 2025 · 6 likes On post #9 — agreed on the reasoning, with one qualification. Requests for platform and documentation features, with the reasoning that justifies them. If you think the…
-
What this community means by "a source", in practical terms Replied, post #16 · Start Here › Welcome · 26 Jun 2025 · 0 likes post #15 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #144 · Access › Insurance & coverage · 16 Jun 2025 · 18 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #63 · Compounds › Retatrutide · 11 Jun 2025 · 14 likes Hepatic effects: glucagon receptor agonism promotes hepatic fat oxidation, which is mechanistically plausible for benefit in metabolic liver disease. Whether that…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #31 · Compounds › Cagrilintide & amylin analogues · 7 Jun 2025 · 6 likes Picking up post #28: that is the part I would want checked first. Cagrilintide alone is discussed less than in combination because the published data is almost entirely…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #63 · Practice › Reconstitution · 3 Jun 2025 · 29 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
-
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #17 · Practice › Dosing & titration · 30 May 2025 · 2 likes post #16 is right about the mechanism and I think understates the practical bit. Titrating on tolerability rather than on the calendar: some people escalate when they…
-
Titles that describe the question, not the situation Replied, post #15 · Start Here › How to Ask · 23 May 2025 · 16 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #93 · Practice › Interactions · 20 May 2025 · 1 like Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration…
-
Coming back to: Official shortage notices and what they authorise Replied, post #10 · Access › Shortages · 20 May 2025 · 1 like post #9 is right about the mechanism and I think understates the practical bit. Allocation and rationing: during severe shortages, suppliers might ration allocation to…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #40 · Compounds › Cagrilintide & amylin analogues · 9 May 2025 · 23 likes post #39 is right about the mechanism and I think understates the practical bit. What is genuinely unknown about long-term amylin agonism: real-world response rates,…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #74 · Clinical › Comorbidities · 3 May 2025 · 0 likes post #73 answers the question as asked. The question underneath it is different. Type 2 diabetes: the population with the largest evidence base for these compounds. The…
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #4 · marked as the solution · Compounds › Oral incretins · 2 May 2025 · 7 likes Oral bioavailability is variable between people. Some people absorb well; others absorb poorly. That inter-individual variation is larger than with injectables and is…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #42 · Wellbeing › Mental health · 29 Apr 2025 · 1 like When to involve a professional: if mood changes are persistent, deepen over weeks, or interfere with function, involving a mental health professional is appropriate.…
-
Water content on a certificate and why it changes the arithmetic Replied, post #6 · Analytics › COA interpretation · 26 Apr 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #134 · Pharmacology › Receptor biology · 20 Mar 2025 · 28 likes Coming back to post #132, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Coverage for the indication versus for the drug — a second dataset Replied, post #23 · Access › Insurance & coverage · 17 Mar 2025 · 0 likes Tier placement and step therapy: some formularies place a medication on a higher tier or require you to fail cheaper alternatives before approving the one you want.…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #9 · Sourcing › Vendor reports · 15 Mar 2025 · 22 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
Oxidation and deamidation mass shifts, tabulated Replied, post #62 · Analytics › Mass spectrometry · 27 Feb 2025 · 5 likes I read post #60 twice before replying, because I had assumed the opposite. Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you expect mostly…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #8 · Access › Pricing · 12 Feb 2025 · 10 likes Biosimilars and future generics: as patents expire, biosimilar and generic versions might become available and prices might fall. That has already happened for some…
-
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #46 · Clinical › Bloodwork · 6 Feb 2025 · 32 likes Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than most people realize. Comparing your result to the reference…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #5 · Clinical › Comorbidities · 28 Jan 2025 · 21 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #4 · Practice › Reconstitution · 16 Jan 2025 · 33 likes A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
-
Anaesthesia and elective surgery: the aspiration question — does this still hold? Replied, post #18 · Practice › Interactions · 15 Jan 2025 · 0 likes I read post #16 twice before replying, because I had assumed the opposite. Metformin: commonly co-administered and relevant to gastrointestinal tolerability.…
-
Follow-up: Individual participant data versus aggregate data Replied, post #29 · Evidence › Meta-analyses · 9 Jan 2025 · 1 like Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating the same thing and variation is sampling error. Random-effects assumes…
-
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #11 · Clinical › Bloodwork · 7 Jan 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #32 · Wellbeing › Mental health · 29 Dec 2024 · 25 likes This follows post #29 rather than contradicting it. Body image and weight loss: large weight loss changes a person's relationship with their body in ways that can be…
-
Transit times by route, from a logged dataset — the long version Replied, post #43 · Sourcing › Logistics · 27 Dec 2024 · 4 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Fixed versus detachable needles: the trade-offs Replied, post #58 · Devices › Syringes & needles · 19 Dec 2024 · 0 likes Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard), or 10-12 mm (longer). Longer needles are needed for deeper tissue or if…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #117 · Clinical › Prescriber conversations · 7 Dec 2024 · 3 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
-
Converting between mg/mL and units per dose, both directions Replied, post #107 · Practice › Reconstitution · 28 Nov 2024 · 3 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
-
Promotion criteria, and the one that stops most nominations Replied, post #118 · Documentation › Doc review · 20 Nov 2024 · 0 likes Picking up post #115: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #18 · Compounds › Repair & healing peptides · 9 Nov 2024 · 22 likes Picking up post #15: that is the part I would want checked first. Analytical identity of BPC-157: a 15-residue peptide with an unambiguous mass (≈1419.5 Da). Identity…
-
Taste changes and food aversion, reported and discussed Replied, post #38 · Practice › Side effects · 8 Nov 2024 · 0 likes This follows post #35 rather than contradicting it. Delayed gastric emptying: the mechanism behind much of the gastrointestinal side-effect profile. At extreme…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #94 · Practice › Dosing & titration · 31 Oct 2024 · 1 like Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #30 · Compounds › Semaglutide · 22 Oct 2024 · 0 likes The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works. Below 4 half-lives you are not approaching steady state yet, which is…
-
Choosing which test to pay for, given a fixed budget — does this still hold? Replied, post #2 · Sourcing › Independent verification · 17 Oct 2024 · 1 like the opening post is right about the mechanism and I think understates the practical bit. VendorInvestigate: documentation and supplier-practice review. Reviews…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #47 · Access › Shortages · 10 Oct 2024 · 5 likes Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply returns is different from gradually tapering. The two are…
-
Converting between mg/mL and units per dose, both directions Replied, post #39 · Practice › Reconstitution · 4 Oct 2024 · 6 likes A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #75 · Practice › Dosing & titration · 2 Oct 2024 · 8 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #26 · Compounds › Tirzepatide · 2 Oct 2024 · 0 likes This follows post #23 rather than contradicting it. SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to…
-
Converting between mg/mL and units per dose, both directions Replied, post #10 · Practice › Reconstitution · 3 Sep 2024 · 2 likes On post #6 — agreed on the reasoning, with one qualification. Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and…
-
High-resolution MS on aggregates and what it can see — one year on Replied, post #16 · Analytics › Mass spectrometry · 12 Aug 2024 · 10 likes On post #12 — agreed on the reasoning, with one qualification. Desalting before analysis: some samples need desalting to remove salts that suppress the peptide signal.…
-
Reporting a discrepancy without making an allegation Replied, post #8 · Sourcing › Vendor reports · 29 Jul 2024 · 7 likes Testing service selection: Janoshik gives purity with chromatogram. Medutest gives combined purity and identity. PeptideMeter gives verification records as well as…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #45 · Compounds › Retatrutide · 19 Jul 2024 · 16 likes On post #41 — agreed on the reasoning, with one qualification. Mass and identity: a report on retatrutide should state the mass detected by LC-MS, not assume a…
-
Oral contraceptives and delayed emptying: what the data shows Replied, post #52 · Practice › Interactions · 16 Jul 2024 · 3 likes Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or…
-
Cold packs, phase-change material, and what survives ten days Replied, post #93 · Sourcing › Logistics · 11 Jul 2024 · 18 likes Documentation after arrival: photograph the parcel and its contents on arrival. If something later turns out wrong (damage, loss, wrong item) you have evidence of the…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #122 · Practice › Dosing & titration · 10 Jul 2024 · 1 like I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #117 · Practice › Dosing & titration · 10 Jul 2024 · 0 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…
-
Oral contraceptives and delayed emptying: what the data shows Replied, post #4 · Practice › Interactions · 5 Jul 2024 · 21 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
-
Follow-up: Oral contraceptives and delayed emptying: what the data shows Replied, post #4 · Practice › Interactions · 28 Jun 2024 · 13 likes post #3 answers the question as asked. The question underneath it is different. Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin…
-
Coming back to: Preparing for an appointment: one page, three questions Started this topic · Clinical › Prescriber conversations · 27 May 2024 · 0 likes Posting this under the heading it deserves: Preparing for an appointment: one page, three questions Everything below is what sits behind that. General question, not a…